VIVEbiotech News and Resources

VIVEbiotech, a Contract Development and Manufacturing Organization (CDMO) specialising in lentiviral vector production, has secured a growth equity investment from Ampersand Capital Partners. This collaboration will allow the company to enhance its manufacturing capabilities and serve a growing pipeline of